Related Experiment Video
Updated: May 10, 2026

5/6th Nephrectomy in Combination with High Salt Diet and Nitric Oxide Synthase Inhibition to Induce Chronic Kidney Disease in the Lewis Rat
Published on: July 3, 2013
Factors associated to salt intake in chronic hemodialysis patients
Fabiana Baggio Nerbass1, Jyana Gomes Morais, Rafaela Gonzaga dos Santos
1Pro-Kidney Foundation, Joinville, SC. fabiana@prorim.com.br
Introduction:
Salt intake increases fluid intake and, consequently, blood pressure (BP) and interdialytic weight gain (IDWG), known as morbi-mortality risk factors for hemodialysis (HD) patients.
Objective:
Evaluate salt intake and food sources, as well as its relationship with demographics, clinical and nutritional parameters.
Methods:
Cross-sectional study with 109 patients (66% women, age = 49.0 ± 12.6 years) from five dialysis centers. For total salt intake, a validated food frequency questionnaire (FFQ) and the use of discretionary salt were estimated. The relationship of salt intake with many factors was studied.
Results:
Salt intake was high (8.6 ± 5.4 g/day) and 72% came from discretionary salt. Only literacy was significantly correlated total salt intake (r = -0.29, p < 0.01) and discretionary salt (r = -0.30, p < 0.01). With FFQ food items, there was a positive correlation with the %IDWG (r = 0.26, p < 0.01) and negative with age (r = -0.35, p < 0.001). Direct relationship between salt intake with %IDWG was found in the anuric subgroup (r = 0.26, p < 0.05) and with medium BP in those with no prescription of hypotensive drugs (r = 0.35, p < 0.05).
Conclusion:
Salt intake was high mainly due to discretionary salt. It was associated with education and adversely affected %IDWG in anuric patients and medium BP in those not taking hypotensive drugs.
Related Concept Videos
Hemodialysis II: Procedure and Complications
Chronic Kidney Disease III: Interprofessional Care
Hemodialysis III: Nursing Management
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease IV: Nursing Management
Heart Failure VI: Adjunct Therapies